Phase III randomized study of dacarbazine with or without allovectin-7 in patients with metastatic melanoma

Trial Profile

Phase III randomized study of dacarbazine with or without allovectin-7 in patients with metastatic melanoma

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2011

At a glance

  • Drugs Dacarbazine; Velimogene aliplasmid
  • Indications Malignant melanoma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 06 Jun 2011 Results presented at 47th Annual Meeting of the American Society of Clinical Oncology (ASCO-2011).
    • 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 28 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top